Plus: NTxBio to invest $31 million to build biomanufacturing facility in Plano and Vonlane to launch nonstop service from ...

Following after is P-500, a selective, brain-penetrant PRMT5 inhibitor for advanced solid tumours, including high-grade ...

New York has added $10 million to its NYFIRST program to attract top research talent and boost biotech innovation, among other goals.

By Rexford GYAMPASince the National Biosafety Authority (NBA) approved the commercialization of 14 Genetically Modifies Products, (GMO) the country’s food marked has been flooded with a lot of such ...

Microsoft, Chevron, 10x Genomics, 23andMe, NetApp, NGM Biopharmaceuticals, Pliant Therapeutics and Downtown College Prep are ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

Key Takeaways Novo Nordisk is teaming up with U.S. biotech Septerna to create a new obesity pillSepterna could receive up to ...

Awarded earlier this year, the $44M Birmingham Biotechnology Hub grant was set to support the growth of Alabama's ...

The star of the acquisition is the enzyme replacement therapy INZ-701, being developed for the rare disease ENPP1 deficiency.

The American Society of Gene and Cell Therapy (ASGCT) meeting is off and running in New Orleans! Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN are on ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...